Founded in 2015, Sayre Therapeutics is backed by leading institutional investors and VCs. With 25 years of global expertise in pharmaceuticals, medical diagnostics, and devices, we have established a strong clinician network and a first-mover advantage in Oncology, Rare & Orphan-Disease care.
Operating across India, South Asia, and Southeast Asia, we focus on rare disease areas, leveraging our strategic partnerships, financial strength, and regulatory expertise to deliver differentiated global assets to emerging markets.
We will become Asia’s specialized healthcare company of choice, providing patients and clinicians access to high-quality novel medical solutions for life-threatening diseases.
Leading the way by providing access to innovative and affordable treatment options, to improve the quality of life.
We will become Asia’s specialized healthcare company of choice, providing patients and clinicians access to high-quality novel medical solutions for life-threatening diseases.
Leading the way by providing access to innovative and affordable treatment options, to improve the quality of life.
Chief Executive Officer
Shukrit has a proven track record in the pharmaceutical industry and prior to Sayre Therapeutics, he served as Vice-President and India / South-Asia Head, Branded Formulations at Biocon, Bangalore, India. His responsibilities spanned the breadth of commercial operations including P&L management. Additionally, he headed global business development for the vertical, and directed strategies across eight business units, driving global in-licensing for them. His earlier roles at the premier Indian biotech included heading the Novel Medicines out-licensing and Biosimilars’ verticals. …
Head, Finance & Administration
Rajesh comes with 15 plus years of experience across different functions in the pharmaceutical industry with deep experience in Finance and Administration. Prior to joining Sayre, he has worked with Biocon and has received awards for excellence in Oncology.
At Sayre he is part of the core leadership team and is a founding member. He is a highly organized and creative problem solver who excels at guiding teams through challenging projects. He is responsible for business operations, finance, and administration. He exhibits a can-do attitude and drives with passion and purpose in Sayre’s fast-paced cross-functional environment.
He holds an MBA in HR and Administration. His hobbies include playing badminton, listening to music, and reading.
At Sayre Therapeutics, our commitment to healthcare extends beyond business—we believe in making a lasting impact on society by improving access to life-saving treatments, empowering communities, and driving healthcare awareness.
With a vision of impacting lives beyond medicine, our CSR initiatives reflect our dedication to compassionate care, inclusivity, and social responsibility.
At Sayre Therapeutics, we bridge cutting-edge science with compassionate care, ensuring life-saving treatments reach those who need them most.
Through innovation, accessibility, and ethical healthcare, we transform breakthroughs into real-world impact for patients battling rare diseases.
Our commitment goes beyond medicine—we create pathways for hope, empowering lives with better healthcare solutions.
